Antiviral Patents – How Prepared Are We to Combat Novel Viral Diseases? April 2, 2020 Watch recording Watch now With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral patents. By analyzing both the quality and quantity of the patent portfolios of the world’s leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases. Watch our webinar to learn more about: The entire technology field and key players in antiviral vaccine marketReview of selected companies who have technologies related to coronavirusPortfolio landscaping of global pharma leaders in antiviral patentsHow LexisNexis® PatentSight® metrics evaluate the portfolio strength View the Antiviral Patents – How Prepared Are We to Combat Novel Viral Diseases? slides get the deck Provide actionable insights to support strategic decision-making Effectively communicate the value of your IP with powerful insights and visualizations, enabling you to turn your patent department into a strategic consulting unit. Taking patent analytics out of the ‘black box’ With LexisNexis® Intellectual Property Solutions, you benefit from a highly transparent scientific approach to patent data analysis. Forget opaque algorithms and analytics ‘black boxes’, we can show you exactly how we reached at our insights. Patent analytics solution, PatentSight®, is built on the foundation of ground-breaking validated research, which is often cited in leading scientific publications. Brought together in the patent value indicator, the Patent Asset Index™, this objective approach to assessing patent quality and benchmarking patent portfolios has become a de facto standard in measuring portfolio strength. High-quality data: a prerequisite for reliable patent analysis LexisNexis Intellectual Property Solutions validates and quality-assures patent data by assigning patents to their accurate commercial owners and verifying their legal validity and remaining lifetime. Superior datasets allow you to unveil valuable patent insights and see clearly who wields commercial power over the inventions that underpin promising patents. Patent analyses conducted with PatentSight have proven to be more reliable than analyses based on unprocessed patent data. Was this post helpful? Let us know if you liked the post. That’s the only way we can improve. Yes No
Antiviral Patents – How Prepared Are We to Combat Novel Viral Diseases? April 2, 2020 Watch recording Watch now With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral patents. By analyzing both the quality and quantity of the patent portfolios of the world’s leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases. Watch our webinar to learn more about: The entire technology field and key players in antiviral vaccine marketReview of selected companies who have technologies related to coronavirusPortfolio landscaping of global pharma leaders in antiviral patentsHow LexisNexis® PatentSight® metrics evaluate the portfolio strength View the Antiviral Patents – How Prepared Are We to Combat Novel Viral Diseases? slides get the deck Provide actionable insights to support strategic decision-making Effectively communicate the value of your IP with powerful insights and visualizations, enabling you to turn your patent department into a strategic consulting unit. Taking patent analytics out of the ‘black box’ With LexisNexis® Intellectual Property Solutions, you benefit from a highly transparent scientific approach to patent data analysis. Forget opaque algorithms and analytics ‘black boxes’, we can show you exactly how we reached at our insights. Patent analytics solution, PatentSight®, is built on the foundation of ground-breaking validated research, which is often cited in leading scientific publications. Brought together in the patent value indicator, the Patent Asset Index™, this objective approach to assessing patent quality and benchmarking patent portfolios has become a de facto standard in measuring portfolio strength. High-quality data: a prerequisite for reliable patent analysis LexisNexis Intellectual Property Solutions validates and quality-assures patent data by assigning patents to their accurate commercial owners and verifying their legal validity and remaining lifetime. Superior datasets allow you to unveil valuable patent insights and see clearly who wields commercial power over the inventions that underpin promising patents. Patent analyses conducted with PatentSight have proven to be more reliable than analyses based on unprocessed patent data. Was this post helpful? Let us know if you liked the post. That’s the only way we can improve. Yes No
